D-dimer rise in outpatients with COVID 19 and comorbidities
Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society, Belgrade
2021-01-01
|
Series: | Opšta Medicina |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101047M.pdf |
_version_ | 1818995802396164096 |
---|---|
author | Miljković Ana R. |
author_facet | Miljković Ana R. |
author_sort | Miljković Ana R. |
collection | DOAJ |
description | Introduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases, diabetes, chronic pulmonary diseases, malignant diseases are at higher risk for the severe form of the disease. Case report: Female patient, 57, physician, presents with symptoms of Sars-Cov-2 virus infection. Her personal history is significant for pulmonary thromboembolism (PTE). This is a disease which should be paid special attention to. Conclusion: A new Coronavirus infection, which struck the world a year ago, presents a great challenge for general physicians (GPs) and the health system as a whole. The scientific and medical community and the general public must lean on verified facts in this fight against the COVID-19 pandemic. They should be ready to change their treatment protocols, as new information appears from properly designed, implemented, and presented basic and clinical studies. Each patient should be approached with special care, using up-todate facts and proofs from clinical practice, and guided by the newest treatment protocols thus reducing complications in COVID-19 patients with comorbidities. |
first_indexed | 2024-12-20T21:19:38Z |
format | Article |
id | doaj.art-b64e7e57dc664c6cbde2f3ebf63d26c5 |
institution | Directory Open Access Journal |
issn | 0354-7132 2217-3994 |
language | English |
last_indexed | 2024-12-20T21:19:38Z |
publishDate | 2021-01-01 |
publisher | Serbian Medical Society, Belgrade |
record_format | Article |
series | Opšta Medicina |
spelling | doaj.art-b64e7e57dc664c6cbde2f3ebf63d26c52022-12-21T19:26:19ZengSerbian Medical Society, BelgradeOpšta Medicina0354-71322217-39942021-01-01271-2475210.5937/opmed2102047M0354-71322101047MD-dimer rise in outpatients with COVID 19 and comorbiditiesMiljković Ana R.0Dom zdravlja, Novi Sad, SerbiaIntroduction: COVID-19 is an infectious disease caused by a newly discovered Coronavirus. Most of the infected people will go through it with mild to moderate respiratory symptoms and recover without any specific treatment. Older people and people with medical issues, such as cardiovascular diseases, diabetes, chronic pulmonary diseases, malignant diseases are at higher risk for the severe form of the disease. Case report: Female patient, 57, physician, presents with symptoms of Sars-Cov-2 virus infection. Her personal history is significant for pulmonary thromboembolism (PTE). This is a disease which should be paid special attention to. Conclusion: A new Coronavirus infection, which struck the world a year ago, presents a great challenge for general physicians (GPs) and the health system as a whole. The scientific and medical community and the general public must lean on verified facts in this fight against the COVID-19 pandemic. They should be ready to change their treatment protocols, as new information appears from properly designed, implemented, and presented basic and clinical studies. Each patient should be approached with special care, using up-todate facts and proofs from clinical practice, and guided by the newest treatment protocols thus reducing complications in COVID-19 patients with comorbidities.https://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101047M.pdfd-dimercovid-19comorbiditypulmonary thromboembolismgeneral practice |
spellingShingle | Miljković Ana R. D-dimer rise in outpatients with COVID 19 and comorbidities Opšta Medicina d-dimer covid-19 comorbidity pulmonary thromboembolism general practice |
title | D-dimer rise in outpatients with COVID 19 and comorbidities |
title_full | D-dimer rise in outpatients with COVID 19 and comorbidities |
title_fullStr | D-dimer rise in outpatients with COVID 19 and comorbidities |
title_full_unstemmed | D-dimer rise in outpatients with COVID 19 and comorbidities |
title_short | D-dimer rise in outpatients with COVID 19 and comorbidities |
title_sort | d dimer rise in outpatients with covid 19 and comorbidities |
topic | d-dimer covid-19 comorbidity pulmonary thromboembolism general practice |
url | https://scindeks-clanci.ceon.rs/data/pdf/0354-7132/2021/0354-71322101047M.pdf |
work_keys_str_mv | AT miljkovicanar ddimerriseinoutpatientswithcovid19andcomorbidities |